A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma

By          

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 645-650

Spandidos Publications

Access to resources Recommend Favorite

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors

By Macaulay V. M.   Middleton M. R.   Protheroe A. S.   Tolcher A.   Dieras V.   Sessa C.   Bahleda R.   Blay J.-Y.   LoRusso P.   Mery-Mignard D.   Soria J.-C.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 784-791

Oxford University Press

Access to resources Recommend Favorite

Insulin-like growth factor receptor-1 expression predicts postoperative recurrence in adenocarcinoma of the lung

By            

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 585-590

Spandidos Publications

Access to resources Recommend Favorite

miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor

By Guo Jinling   Xia Bairong   Meng Fanling   Lou Ge  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1557-1564

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma

By Karabulut S.   Duranyıldız D.   Tas F.   Gezer U.   Akyüz F.   Serilmez M.   Ozgür E.   Yasasever C.   Vatansever S.   Aykan N.  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2729-2739

Springer Publishing Company

Access to resources Recommend Favorite